Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like Genentech Gets a Phase III Win With Hemophila A Drug Hemlibra November 19, 2017 2 Biotech Stocks That Exploded 500%+ in the Last 3 Years June 25, 2017 Qiagen Plans to Create Up to 800 Jobs at New UK Campus Post Brexit November 26, 2017
